White blood cell (WBC) count detection is a core hematological endpoint for quantifying inflammatory responses in murine mastitis models. This technical article details the sample types, analytical parameters, detection methodologies, and application scenarios for leukocyte counting in mice with experimentally induced mammary gland inflammation, providing reliable data support for preclinical pharmacology, anti-inflammatory drug screening, and mastitis pathogenesis research.
Technical Overview
Mastitis is the inflammation of mammary gland tissue, typically reproduced in mice through intramammary inoculation of lipopolysaccharide (LPS) or viable pathogens such as Staphylococcus aureus, Escherichia coli, and Streptococcus uberis via the teat canal. Following induction, the host mounts a characteristic inflammatory response dominated by rapid neutrophil mobilization, peripheral leukocytosis, and massive leukocyte infiltration into the glandular stroma. White blood cell count detection therefore serves as a quantitative, sensitive, and reproducible indicator for evaluating both the severity of inflammation and the efficacy of therapeutic interventions.
In a typical murine mastitis protocol, female mice (commonly BALB/c, C57BL/6, or ICR/CD-1 strains, frequently at mid-lactation days 9–10) receive intramammary challenge, and blood or tissue samples are collected at defined time points—commonly 6, 12, 24, and 48 hours post-induction. Peripheral WBC counts, differential leukocyte profiles, and gland-infiltrating leukocyte densities are then measured using validated hematological and flow cytometric methods, with procedures aligned to internationally recognized laboratory quality frameworks such as ISO 15189 principles and relevant GB laboratory animal standards.
Testing Samples
Peripheral Blood
Whole blood is collected from the tail vein, submandibular vein, or retro-orbital sinus into EDTA-coated microtubes. A volume of 20–50 µL is generally sufficient for automated hematology analysis, with additional volume reserved for blood smear preparation. Proper anticoagulation and prompt analysis (within 4 hours of collection) are essential to prevent leukocyte aggregation and count distortion.
Mammary Gland Tissue Homogenate
The inguinal or abdominal mammary glands are harvested under deep anesthesia, weighed, and homogenized in sterile cold phosphate-buffered saline. The resulting suspension is centrifuged, and the pellet or supernatant is used to quantify infiltrating leukocytes, enabling assessment of the localized inflammatory burden independent of systemic blood counts.
Mammary Lavage Fluid
Ductal lavage of the mammary gland collects luminal exudate and migrated neutrophils. This minimally invasive approach allows serial monitoring of leukocyte recruitment within the same animal and is particularly valuable for longitudinal pharmacodynamic studies.
Draining Lymph Node and Bone Marrow Suspensions
For mechanistic studies, single-cell suspensions from the inguinal lymph nodes and bone marrow may be prepared to evaluate leukocyte mobilization, myelopoiesis, and adaptive immune activation associated with the mastitic response.
Testing Items
The core testing panel for leukocyte evaluation in mastitis mouse models includes the following parameters:
- Total white blood cell (WBC) count, reported as ×10⁹/L or ×10³/µL
- Differential leukocyte count: neutrophils, lymphocytes, monocytes, eosinophils, and basophils
- Absolute neutrophil count (ANC) and absolute lymphocyte count (ALC)
- Neutrophil-to-lymphocyte ratio (NLR) as an integrated inflammatory index
- Leukocyte infiltration density in mammary tissue, expressed as cells per mg of tissue
- Complementary inflammatory endpoints: myeloperoxidase (MPO) activity, IL-1β, IL-6, TNF-α levels, and histopathological scoring
During acute mastitis, total WBC and neutrophil percentages typically rise markedly within 12–24 hours post-challenge, while effective anti-inflammatory treatment normalizes these values toward baseline reference intervals for the corresponding mouse strain.
Testing Methods
Multiple complementary methodologies are employed depending on study objectives, sample type, and required sensitivity:
- Automated hematology analysis: Impedance-based (Coulter principle) or laser-based flow cytometric hematology analyzers configured with murine-specific software settings provide rapid total and differential WBC counts from small blood volumes, with daily quality control using species-appropriate control materials.
- Manual hemocytometer counting: Blood or homogenate samples are diluted in acetic acid-based diluent (Türk solution) to lyse erythrocytes, and leukocytes are counted in a Neubauer chamber under microscopy. This method serves as a reference technique and a verification tool for low-volume or matrix-complex samples.
- Wright–Giemsa blood smear microscopy: Stained peripheral smears are evaluated by manual differential counting of 100–200 leukocytes, confirming analyzer results and enabling morphological assessment such as toxic granulation or left shift.
- Flow cytometric immunophenotyping: Single-cell suspensions from blood or mammary tissue are stained with CD45, Ly6G, F4/80, CD11b, CD3, and B220 markers to precisely enumerate total leukocytes, neutrophils, macrophages, and lymphocyte subsets, following fluorescence-minus-one controls and standardized gating strategies.
- Histochemical and cytokine correlation assays: MPO activity assays and enzyme-linked immunosorbent assays for pro-inflammatory cytokines are integrated with WBC data to provide a multidimensional inflammatory profile.
All procedures are performed under institutional animal care protocols consistent with national laboratory animal welfare and husbandry standards, with sample handling, instrument calibration, and data reporting conducted under documented quality management systems in accredited third-party laboratories or GLP-compliant preclinical facilities.
Applications
White blood cell count detection in mastitis mouse models supports a wide range of research and development activities:
- Efficacy evaluation of anti-inflammatory drugs, antibiotics, and botanical or natural product extracts against experimentally induced mammary inflammation
- Pathogenesis research on endotoxin-triggered and bacterial mastitis, including neutrophil recruitment kinetics and cytokine cascades
- Immunomodulator and probiotic intervention studies aiming to attenuate excessive inflammatory responses
- Comparative formulation screening and dose–response characterization in preclinical pharmacology programs
- Mechanistic toxicology and safety pharmacology studies involving mammary gland liability assessment
- Academic publication support, providing standardized and statistically robust hematological datasets
FAQ
What is the normal white blood cell range in mice? Reference intervals vary by strain, age, and sampling site, but total WBC counts in healthy adult mice typically fall within approximately 2–10 ×10⁹/L, with lymphocytes predominating. Strain-specific baselines should be established or cited when interpreting mastitis model data.
How is the murine mastitis model established? The most common approach involves infusion of LPS or a standardized bacterial suspension through the teat canal of lactating or nulliparous female mice under anesthesia, followed by sample collection at predefined time points. Non-invasive clinical scoring and histopathology are usually performed in parallel to validate model success.
How much blood is required for testing? Automated hematology analysis generally requires 20–50 µL of EDTA-anticoagulated blood, while manual hemocytometer counting can be performed with as little as 10 µL, making the method suitable for serial sampling in individual mice.
What is the typical turnaround time? Routine WBC and differential counts can be reported within 3–5 working days after sample receipt, while studies incorporating flow cytometry, cytokine assays, or histopathology may require 7–10 working days depending on the study design.
Which standards and guidelines govern the testing? Procedures are aligned with ISO 15189 quality management principles, clinical laboratory hematology guidelines for leukocyte enumeration and differentials, and national laboratory animal care and usage standards, ensuring data integrity, traceability, and reproducibility.
Can blood and tissue leukocyte data be combined? Yes. Integrating peripheral WBC counts with mammary gland infiltration densities and cytokine profiles provides a comprehensive picture of systemic versus local inflammation, substantially strengthening the interpretive value of the study.